United Orthopedic Corporation(TW:4129)
NT$72.700.00 (0.00%)
TW:4129
United Orthopedic Corporation financials statements
NT$72.70
At close:0.00 (0.00%)
United Orthopedic Corporation (4129) Ratios
United Orthopedic Corporation Ratios
TW:4129's free cash flow for Q2 2026 was NT$-135.16M. For the 2026 fiscal year, TW:4129's free cash flow was decreased by NT$-177.02M and operating cash flow was NT$41.87M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.72 | 1.55 | 1.79 | 1.52 | 1.25 |
| Quick Ratio | 0.89 | 0.79 | 0.90 | 0.77 | 0.68 |
| Cash Ratio | 0.27 | 0.25 | 0.24 | 0.23 | 0.33 |
| Solvency Ratio | 0.30 | 0.30 | 0.28 | 0.22 | 0.15 |
| Operating Cash Flow Ratio | 0.41 | 0.29 | 0.23 | 0.20 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 1.01 | 0.54 | 0.58 | 0.41 | 0.26 |
| Net Current Asset Value | NT$ 671.87M | NT$ 732.88M | NT$ 560.99M | NT$ 115.82M | NT$ -4.61M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 0.26 | 0.25 | 0.28 | 0.33 |
| Debt-to-Equity Ratio | 0.50 | 0.48 | 0.47 | 0.53 | 0.63 |
| Debt-to-Capital Ratio | 0.33 | 0.33 | 0.32 | 0.34 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.17 | 0.08 | 0.17 | 0.15 | 0.07 |
| Financial Leverage Ratio | 1.91 | 1.83 | 1.83 | 1.88 | 1.93 |
| Debt Service Coverage Ratio | 1.03 | 0.71 | 1.05 | 0.70 | 0.34 |
| Interest Coverage Ratio | 16.12 | 14.45 | 12.31 | 14.17 | 9.15 |
| Debt to Market Cap | 0.17 | 0.19 | 0.20 | 0.36 | 0.62 |
| Interest Debt Per Share | 21.48 | 19.84 | 19.88 | 20.45 | 22.34 |
| Net Debt to EBITDA | 1.09 | 1.16 | 1.25 | 1.74 | 2.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 77.79% | 77.85% | 77.26% | 67.12% | 63.44% |
| EBIT Margin | 13.10% | 13.29% | 14.08% | 10.80% | 6.27% |
| EBITDA Margin | 22.63% | 23.17% | 24.17% | 21.41% | 18.31% |
| Operating Profit Margin | 13.10% | 13.41% | 13.82% | 10.80% | 6.27% |
| Pretax Profit Margin | 13.37% | 12.36% | 12.96% | 12.58% | 4.82% |
| Net Profit Margin | 9.95% | 9.81% | 9.78% | 7.01% | 2.03% |
| Continuous Operations Profit Margin | 10.10% | 9.89% | 9.88% | 7.07% | 2.06% |
| Net Income Per EBT | 74.37% | 79.36% | 75.45% | 55.71% | 42.12% |
| EBT Per EBIT | 102.12% | 92.16% | 93.73% | 116.42% | 76.87% |
| Return on Assets (ROA) | 7.19% | 6.48% | 5.99% | 3.95% | 1.00% |
| Return on Equity (ROE) | 13.72% | 11.85% | 10.98% | 7.40% | 1.92% |
| Return on Capital Employed (ROCE) | 13.92% | 13.66% | 12.00% | 8.81% | 4.87% |
| Return on Invested Capital (ROIC) | 8.77% | 8.44% | 7.81% | 5.76% | 2.88% |
| Return on Tangible Assets | 7.79% | 7.06% | 6.57% | 4.39% | 1.11% |
| Earnings Yield | 5.12% | 5.14% | 5.35% | 5.93% | 2.13% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.16 | 3.84 | 3.60 | 3.72 | 4.12 |
| Payables Turnover | 5.88 | 7.86 | 4.26 | 6.79 | 8.49 |
| Inventory Turnover | 0.61 | 0.55 | 0.53 | 0.80 | 0.85 |
| Fixed Asset Turnover | 2.60 | 2.36 | 2.22 | 1.91 | 1.63 |
| Asset Turnover | 0.72 | 0.66 | 0.61 | 0.56 | 0.49 |
| Working Capital Turnover Ratio | 3.60 | 3.27 | 3.28 | 4.53 | 3.60 |
| Cash Conversion Cycle | 628.52 | 712.01 | 706.56 | 501.04 | 473.54 |
| Days of Sales Outstanding | 87.80 | 95.09 | 101.41 | 98.00 | 88.70 |
| Days of Inventory Outstanding | 602.77 | 663.35 | 690.91 | 456.83 | 427.84 |
| Days of Payables Outstanding | 62.05 | 46.43 | 85.76 | 53.79 | 42.99 |
| Operating Cycle | 690.57 | 758.44 | 792.32 | 554.83 | 516.54 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 10.47 | 7.46 | 5.14 | 4.36 | 4.30 |
| Free Cash Flow Per Share | 2.70 | 1.33 | -1.47 | -0.58 | 1.38 |
| Dividend Paid and CapEx Coverage Ratio | 0.89 | 0.74 | 0.57 | 0.88 | 1.06 |
| Capital Expenditure Coverage Ratio | 1.35 | 1.22 | 0.78 | 0.88 | 1.47 |
| Operating Cash Flow Coverage Ratio | 0.50 | 0.39 | 0.27 | 0.22 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.15 | 0.11 | 0.11 | 0.13 |
| Free Cash Flow Yield | 2.41% | 1.44% | -1.73% | -1.22% | 4.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.21 | 19.58 | 18.66 | 16.83 | 85.14 |
| Price-to-Sales (P/S) Ratio | 1.94 | 1.91 | 1.83 | 1.18 | 0.95 |
| Price-to-Book (P/B) Ratio | 2.68 | 2.30 | 2.05 | 1.25 | 0.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 41.49 | 69.39 | -57.96 | -82.21 | 22.83 |
| Price-to-Operating Cash Flow Ratio | 10.70 | 12.38 | 16.54 | 10.96 | 7.33 |
| Price-to-Earnings Growth (PEG) Ratio | 0.82 | 5.58 | 0.31 | 0.03 | -1.35 |
| Enterprise Value Multiple | 9.67 | 9.40 | 8.80 | 7.25 | 7.50 |
| Enterprise Value | 12.38B | 10.13B | 8.36B | 4.91B | 3.54B |
| EV to EBITDA | 9.67 | 9.40 | 8.80 | 7.25 | 7.50 |
| EV to Sales | 2.19 | 2.18 | 2.13 | 1.55 | 1.37 |
| EV to Free Cash Flow | 46.77 | 79.18 | -67.52 | -108.08 | 32.91 |
| EV to Operating Cash Flow | 12.06 | 14.12 | 19.27 | 14.40 | 10.57 |
| Tangible Book Value Per Share | 36.78 | 35.09 | 35.85 | 32.22 | 29.56 |
| Shareholders’ Equity Per Share | 41.82 | 40.09 | 41.48 | 38.34 | 34.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.20 | 0.24 | 0.20 | 0.18 |
| Revenue Per Share | 57.70 | 48.42 | 46.61 | 40.47 | 33.05 |
| Net Income Per Share | 5.74 | 4.75 | 4.56 | 2.84 | 0.67 |
| Tax Burden | 0.74 | 0.79 | 0.75 | 0.56 | 0.42 |
| Interest Burden | 1.02 | 0.93 | 0.92 | 1.16 | 0.77 |
| Research & Development to Revenue | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 |
| SG&A to Revenue | 0.60 | 0.60 | 0.59 | 0.58 | 0.60 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Income Quality | 1.36 | 1.25 | 1.14 | 1.54 | 6.40 |
Currency in TWD
